SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Focused Exome, a target enrichment solution that enables deep coverage of only those target regions that have been associated with disease. The latest design is 16 Mb in size and enables 98 percent of targeted regions to be covered with 20 or more reads with only 3 Gb of sequencing, allowing for sensitive detection of variants within a given sample.
Help employers find you! Check out all the jobs and post your resume.
